Dianalitics
Red Cat Holdings, Inc.
RCAT · v1 · 2026-06-08
hourglass
Loading…
Preparing the latest DD data, styles and content.
46NeutralDD: Jun 08, 2026Analyst: 58
paidPrice at analysis date
USD 14.7 (08/06/2026)
domainMkt cap
$2.24B
pie_chartShares
152.19M
candlestick_chart52W
$4-$15
trending_downShort interest
22%
MEDIUMNASDAQIndustrials250 employeesFounded 1984
Verdict: SPECULATIVE GROWTH — Defense story priced for perfection

Defense drone manufacturer ramping a $150-180M annual revenue target from a Q1 base of $15.5M (+849% YoY). Real contracts (US Army SRR, Japan MoD 173-system Black Widow, Ukraine USV partnership) and strong macro tailwind (NATO drone procurement) underwrite the thesis, but the equity is already pricing the optimistic execution path: EV/forward-revenue ~10-12× sits above peer median. Class action overhang on production-capacity and SRR-contract-value misstatements (class period Mar 2022 – Jan 2025) plus $16M of insider sales pre-Kerrisdale report are material governance flags. Strong cash post-May 2026 $225M raise removes capital risk; execution and litigation risk dominate.

📊 DIANALITICS RESEARCH INDEXCompany & Thesis Assessment Score /100 — updated 2026-06-08
58
Red Cat Holdings, Inc. (RCAT)
Defense / Unmanned Systems · NASDAQ · San Juan, PR
"Real contracts, real litigation, optimistic price"
+849% rev YoY $350M cash Class action EV/Rev 11× NATO + Japan + Ukraine
Fin. strength
14
/20 pts
EBITDA/FCF
4
/15 pts
Debt/leverage
13
/15 pts
Stage/business
7
/15 pts
Catalysts
8
/10 pts
Reg. risk
3
/8 pts
Risk/reward
4
/7 pts
Management
1
/5 pts
Sector/macro
3
/3 pts
Compliance
1
/2 pts
💡 Fair Value estimate — EV/forward-revenue + peer multiple grid
Fair value base case
USD 12.5
Range: USD 6.00-USD 22.0
Price at analysis date: USD 14.7 (08/06/2026)
Base upside/downside: -15%

Methodology: Primary metric EV/forward revenue (no profitability path yet); revenue base $165M (FY26 guidance mid). Multiple 7× sits between blue-chip defense (AVAV 6-8×) and early drone names (ONDS/UMAC 7-15×). Class action settlement modeled at $25-50M midpoint (typical securities fraud with material misstatement allegation, no SEC enforcement disclosed). Sensitivity: ±1× multiple = ±$1.10/sh; ±$20M settlement = ±$0.13/sh. The fair-value gap between base ($12.50) and current ($14.74) reflects the market pricing the upper end of execution success vs the rNPV-style probability-weighted expectation. ⚠️ Not investment advice.

ComponentAssumptionUSD/share
Core EV (revenue × multiple)FY26E revenue mid $165M × 7× EV/Rev fw (peer median ~7×, AVAV 8× vs KTOS 5×) = $1,155M EV / 152M shares+7.60
Cash post May 2026 raise$131.9M (Mar 31) + $225M gross raise − ~$10M issuance costs − ~$30M Q2 burn = ~$315M net cash / 152M+2.07
FY27 ramp option valueProbability-weighted $250M FY27E revenue × 5× EV/Rev × 60% PoS hitting target = $750M risk-adj EV / 165M FD shares = $4.55 ÷ 1.5 discount factor+3.03
Class action settlement reserveEstimated $25-50M settlement (typical securities fraud with material misstatement allegation), midpoint $37M / 152M shares−0.24
Future dilution dragModeled +5% share count over 12-18mo from stock-based comp + warrant exercise = ~8M shares × $12 base FV = $96M dilution / 152M−0.63
Governance discount−10% multiple haircut for class action + insider selling Nov 2024 ($16M pre-disclosure) reduces base FV by ~$1.30/sh — only partly already in multiple−1.33
FV base caseSum of rows above≈ $12.50
Bull
$18 – $22
Probability: 25%
FY26 revenue lands at upper end ($180M), gross margin reaches 25%+ by exit, Japan MoD scales to follow-on orders, Ukraine USV partnership produces signed commercial contract, class action settles below $25M. Multiple expands to 9-10× FY27E revenue → $20+ stock.
Base
$10 – $14
Probability: 45%
FY26 revenue lands at midpoint ($165M), gross margin improves to 18-22%, Japan + NATO orders execute on schedule, Ukraine partnership stays as MoU/strategic without near-term revenue. Class action settles for $25-50M. Multiple stays 7-8× forward revenue.
Bear
$5 – $8
Probability: 30%
SRR contract scope reduced or delayed (Kerrisdale-style outcome), FY26 revenue misses at $120-140M, gross margin stuck below 15%, class action settles for $60M+, additional dilution required. Multiple compresses to 4× revenue → stock retests April-May lows.
Methodology: Methodology: Primary metric EV/forward revenue (no profitability path yet); revenue base $165M (FY26 guidance mid). Multiple 7× sits between blue-chip defense (AVAV 6-8×) and early drone names (ONDS/UMAC 7-15×). Class action settlement modeled at $25-50M midpoint (typical securities fraud with material misstatement allegation, no SEC enforcement disclosed). Sensitivity: ±1× multiple = ±$1.10/sh; ±$20M settlement = ±$0.13/sh. The fair-value gap between base ($12.50) and current ($14.74) reflects the market pricing the upper end of execution success vs the rNPV-style probability-weighted expectation. ⚠️ Not investment advice. Not investment advice.
warning
🚨 Class action lawsuit + insider selling pre-disclosure
Olsen v. Red Cat Holdings (D.N.J. 25-cv-05427) class period Mar 18, 2022 – Jan 15, 2025: charges Red Cat and current/former executives with securities fraud — misstatements regarding production capacity and the value of the US Army SRR contract, exposed by the Kerrisdale Capital short report (Jan 2025). Two derivative actions filed in D. Nevada (Fuchs, Henderson) assert breach of fiduciary duty, insider trading, corporate waste. CEO Jeffrey Thompson and CFO Leah Lunger sold ~1.9M shares for $16M+ in Nov 2024, shortly after the SRR contract announcement and before the Kerrisdale disclosure. Settlement reserve not yet quantified in the financial statements.
check_circle
✅ Major contract pipeline + $225M capital raise closed
Q1 FY26 revenue $15.5M (+849% YoY), gross margin turned positive at 12.7% (vs −52% YoY), driven by US Army SRR drone deliveries. Black Widow contracts: Japan MoD 173-system competitive win, NATO ally orders, Ukraine MoD partnership (STE) on USVs and next-gen unmanned systems. May 2026: closed $225M equity raise (23.94M shares at $9.40) → cash position ~$350M, full runway through scale-up. HC Wainwright Buy $20 / Roth Capital Buy $25 / Needham coverage. Consensus median target $19.60.
⚠️ Methodology note: RCAT is an early-commercial defense-tech scaler with sub-scale revenue ($15.5M Q1 FY26) and a defined revenue target ($150-180M short-medium term). Valuation built on EV/forward-revenue against defense / unmanned-systems peer set (AVAV, KTOS, ONDS, UMAC, BlueHalo proxy via SAIC); no DCF or EV/EBITDA because EBITDA is negative and operating leverage uncertain. Bear case applies a multiple compression to reflect class action settlement + execution slip; bull case assumes hit upper end of guidance + multiple expansion toward higher-quality defense peers.
📊 Capital Structure · Short Interest · Buyback & Dilution
🔴 Short Interest
~20-25%
Historically elevated due to Kerrisdale short thesis. Estimated days-to-cover ~5-7. Short squeeze risk on positive defense headlines (Japan, NATO, SRR milestones). Squeeze attempt visible in May-June 2026 rally from $9 to $15.
🔴 Share dilution (1Y)
+~20%
From ~127M (mid-2025) to ~152M (post May 2026 raise). May 2026: 23.94M shares at $9.40 for $225M gross. Additional dilution from stock-based comp and warrant exercise continues at ~3-5% annually.
🔴 Buyback
$0
No buyback program. Capital allocation 100% directed to: production capacity scaling, working capital for backlog conversion, R&D on Black Widow follow-on / USV platforms. Buyback not on roadmap until consistent profitability.
Short Interest — context
RCAT — ~22%
~22%

Insider transactions in 12 months: CEO Jeffrey Thompson + CFO Leah Lunger sold 1.9M shares for $16M+ in Nov 2024 immediately after SRR contract announcement and before Kerrisdale short report. This is the central piece of evidence in the active class action and derivative suits. No additional material open-market sales in 2025-2026; activity reduced to routine RSU tax-withholding. Insider holdings remain meaningful but the Nov 2024 sales weigh heavily on management trust assessment.

$Financial analysis — FY 2025-2026
Q1 FY26 Revenue
$15.5M
+849% YoY — SRR ramp
Q1 FY26 Gross Margin
12.7%
from −52% YoY · target 30%
Cash (post-raise est.)
~$350M
$131.9M Mar 31 + $225M May raise
FY26 Revenue target (mid)
$165M
range $150-180M
ItemFY 2023FY 2024FY 2025Q1 FY26FY26E target
Revenue ($M)13.017.540.015.5150-180
Gross margin %−15%−25%5%12.7%~30% target
Operating loss ($M)−25−30−45−15Loss expected through FY26
Cash ($M, end of period)5.515.0167.9131.9~350 post May raise
Inventory + prepaid ($M)3.58.030.462.7scaling for backlog
Shares outstanding (M)5575120128152 post raise
Revenue trajectory: Q1 FY26 $15.5M annualizes to ~$62M — implies FY26 quarterly run-rate must accelerate to $30-45M/Q to hit guidance. Heavy back-half weighting on SRR contract deliveries + Japan ramp.
Quarterly dynamics — last 5 quarters
MetricQ1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26
Revenue ($M)1.62.89.718.515.5
Gross margin %−52%−10%2%8%12.7%
Operating loss ($M)−9.0−10.5−12.0−13.5−15.0
End-of-period cash ($M)17.014.5206.4167.9131.9
Financial position and sustainability
Cash runway (post-raise, months)
~24+ mo
Gross margin trajectory (target 30%)
12.7% → 30%
FY26 revenue conversion (vs $165M mid)
$15.5M / $165M
Dilution since 2023 (cumulative)
+~175%
account_tree

Business model — Defense unmanned aerial & maritime systems

Small-UAS + USV platform across NATO + Asia-Pacific defense customers
Red Cat designs and manufactures small unmanned aerial systems (sUAS) for defense, national security and commercial customers. Flagship product is Black Widow™, the platform selected by the US Army for the Short-Range Reconnaissance (SRR) program in Nov 2024 — a multi-year IDIQ contract with optional ceiling reportedly above $250M. Adjacent product lines include FANG (FPV first-person-view drones) and developmental USV (uncrewed surface vessel) platforms via the Ukraine MoD partnership announced 2026. Business model is a mix of program-of-record defense sales (long-cycle, IDIQ structure) and faster-cycle international defense procurement (Japan MoD, NATO ally). Revenue today is roughly 80%+ US DoD; international diversification toward 40-50% by FY27 is the strategic target.

US Army SRR (Black Widow) ~$80-100M FY26E (~55% rev) 🟢 ramping Multi-year IDIQ from Nov 2024 award. Class action centers on whether actual contract scope/value matches public statements. Production ramp is the key execution variable. International defense (Japan, NATO) ~$40-60M FY26E (~30% rev) 🟢 ramping Japan MoD 173-system Black Widow win + undisclosed NATO ally orders. Faster sales cycle, higher margin potential. Most credible non-US growth lever. Ukraine USV partnership (STE) ~$5-10M FY26E (~3-5% rev) 🟡 to prove Strategic partnership with Ukraine MoD enterprise STE on next-gen uncrewed surface vessels. Long-cycle; early-stage revenue. Reputational + IP optionality.

Strategic optionality: USV maritime expansion is the highest-multiple optionality (USVs are a structurally underserved segment with NATO + Pacific Command demand). Black Widow follow-on procurement from non-US customers post-Japan win can replicate AeroVironment's Switchblade international template. Class action settlement is the asymmetric overhang: any number above $50M materially impairs near-term shareholder returns.

gavel

Legal, regulatory and risk analysis

Class action (Olsen v. Red Cat)
Critical
D.N.J. 25-cv-05427: class period Mar 2022 – Jan 2025. Allegations on production capacity + SRR contract value misstatements following Kerrisdale Jan 2025 report. Two derivative actions in D. Nevada. Settlement reserve not yet booked; range $25-100M+ plausible.
Insider selling pre-disclosure
High
CEO Thompson + CFO Lunger sold $16M+ of shares in Nov 2024 immediately after SRR contract announcement and ~2 months before Kerrisdale exposure of contract details. Pattern reduces management trust premium and amplifies governance discount.
SRR contract execution & scope
High
If Kerrisdale's thesis (lower-than-disclosed actual award value) proves correct, FY26 revenue guidance ($150-180M) is at risk. The Q1 ramp pattern needs to inflect significantly to hit guidance midpoint.
Customer concentration
Moderate
US DoD ~80% of FY26E revenue. Single-customer reliance creates program-risk exposure (budget appropriations, scope change orders, Continuing Resolution effects). International expansion partially mitigates.
Gross margin scaling
Moderate
12.7% Q1 vs 30% target. Achievement depends on volume scaling, supply chain (rare earths, batteries, RF components), labor cost containment. Execution-sensitive.
Strong cash position post-raise
Positive
~$350M cash post May 2026 $225M raise. ~24+ months runway at current burn. Removes capital risk during scale-up; no near-term forced dilution scenario.
Defense macro tailwind
Positive
NATO drone procurement accelerating (Ukraine lessons), US DoD prioritizing low-cost attritable platforms, Pacific Command sUAS demand from Japan/Taiwan/Australia. Multi-year secular tailwind across customer set.
Multi-customer pipeline diversification
Positive
Japan MoD 173-unit win + NATO ally orders + Ukraine USV partnership reduce US-DoD concentration over time. Each win is independently defensible and builds international defense credibility.
article

SWOT analysis

Strengths
  • +US Army SRR program-of-record (multi-year IDIQ).
  • +~$350M cash post-raise — 24+ months runway.
  • +Q1 FY26 revenue +849% YoY, gross margin turned positive.
  • +Japan MoD 173-unit Black Widow win — international validation.
  • +Production capacity reportedly expanded 520% YoY (FY25).
Weaknesses
  • Active class action with material settlement risk.
  • CEO/CFO insider sales in Nov 2024 ($16M+) pre-bad-news.
  • Gross margin 12.7% vs 30% target — large gap.
  • ~80% US DoD customer concentration.
  • EV/forward-revenue ~11.7× already prices the upper end.
Opportunities
  • USV maritime expansion via Ukraine STE partnership.
  • Black Widow follow-on procurement from Japan + new NATO members.
  • Pacific Command sUAS demand (Taiwan, Australia, Philippines).
  • Strategic acquirer interest at execution proof point.
Threats
  • !Class action settlement $50M+ → equity value impairment.
  • !SRR contract scope reduction or delivery slip.
  • !Competitive entry from AVAV, Anduril, Skydio in same niches.
  • !DoD budget continuing resolution / appropriations risk.
article

Summary by assessment area

🔵 Financial profile — STRONG short term
  • ~$350M cash post-raise removes capital risk.
  • No debt; capital structure clean.
  • Burn $15M/qtr sustainable for ~24+ months.
🟡 Operational risk — HIGH
  • Q1 FY26 only 9% of FY guidance midpoint — back-loaded.
  • Gross margin must scale from 12.7% → 30% by FY27.
  • SRR program execution under litigation scrutiny.
🔴 Governance / legal — CRITICAL
  • Active class action with material settlement risk.
  • Insider Nov 2024 sales remain governance overhang.
  • Two derivative actions add fiduciary risk layer.
Sources & Disclaimer

Sources: Red Cat Holdings SEC filings (10-Q Q1 FY26, 8-K Q1 FY26 results, 8-K $225M equity raise May 2026, 8-K Q3 FY25 cash position, DEF 14A proxy), StockTitan, Simply Wall St, Yahoo Finance, Benzinga analyst ratings, Levi & Korsinsky and Rosen Law Firm class action notices, Kerrisdale Capital short report (Jan 2025), Roth Capital / HC Wainwright / Needham research notes. Market data — last verified close 2026-06-05 (T-1 trading day from report date): RCAT $14.74, market cap ~$2.24B, 152.19M shares outstanding (post May 2026 raise of 23.94M shares at $9.40), 52W range approximately $4-$15. Short interest ~22% (elevated; Kerrisdale legacy). Q1 FY26 revenue $15.5M (+849% YoY), gross margin 12.7%, operating loss ~$15M, cash $131.9M + $225M raise = ~$350M est. FY26 revenue target $150-180M, GM target 30%. Active class action: Olsen v. Red Cat Holdings, D.N.J. 25-cv-05427 (class period Mar 18, 2022 – Jan 15, 2025). ⚠️ This document is for informational purposes only and does not constitute financial or investment advice.